These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 8688309)

  • 1. Low-molecular-weight heparin vs. unfractionated heparin in femorodistal reconstructive surgery: a multicenter open randomized study. Enoxart Study Group.
    Samama CM; Gigou F; Ill P
    Ann Vasc Surg; 1995; 9 Suppl():S45-53. PubMed ID: 8688309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing vascular surgery.
    Farkas JC; Chapuis C; Combe S; Silsiguen M; Marzelle J; Laurian C; Cormier JM
    Eur J Vasc Surg; 1993 Sep; 7(5):554-60. PubMed ID: 8405501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
    Bergmann JF; Neuhart E
    Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin.
    Winkler MS; Larena-Avellaneda A; Diener H; Kölbel T; Debus ES
    J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):183-92. PubMed ID: 23443603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.
    Chen JL; Chen J; Qiao SB; Guo YL; Wu YJ; Dai J; Yuan JQ; Qin XW; Yang YJ; Gao RL
    Chin Med J (Engl); 2006 Mar; 119(5):355-9. PubMed ID: 16542576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can low molecular weight heparin replace unfractionated heparin during peripheral arterial reconstruction? An open label prospective randomized controlled trial.
    Norgren L;
    J Vasc Surg; 2004 May; 39(5):977-84. PubMed ID: 15111848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
    De A; Roy P; Garg VK; Pandey NK
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial.
    Kakkar VV; Boeckl O; Boneu B; Bordenave L; Brehm OA; Brücke P; Coccheri S; Cohen AT; Galland F; Haas S; Jarrige J; Koppenhagen K; LeQuerrec A; Parraguette E; Prandoni P; Roder JD; Roos M; Rüschemeyer C; Siewert JR; Vinazzer H; Wenzel E
    World J Surg; 1997 Jan; 21(1):2-8; discussion 8-9. PubMed ID: 8943170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety. Enoxaparin Clinical Trial Group.
    Colwell CW; Spiro TE; Trowbridge AA; Morris BA; Kwaan HC; Blaha JD; Comerota AJ; Skoutakis VA
    J Bone Joint Surg Am; 1994 Jan; 76(1):3-14. PubMed ID: 8288662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin in thrombotic disease in children and adolescents.
    Punzalan RC; Hillery CA; Montgomery RR; Scott CA; Gill JC
    J Pediatr Hematol Oncol; 2000; 22(2):137-42. PubMed ID: 10779027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery.
    Renda G; Di Pillo R; D'Alleva A; Sciartilli A; Zimarino M; De Candia E; Landolfi R; Di Giammarco G; Calafiore A; De Caterina R
    Haematologica; 2007 Mar; 92(3):366-73. PubMed ID: 17339186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: A randomized noninferiority trial.
    Olson EJ; Bandle J; Calvo RY; Shackford SR; Dunne CE; Van Gent JM; Zander AL; Sikand H; Bongiovanni MS; Sise MJ; Sise CB
    J Trauma Acute Care Surg; 2015 Dec; 79(6):961-8; discussion 968-9. PubMed ID: 26317819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
    Colwell CW; Spiro TE
    Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin versus unfractionated heparin in the treatment of patients with acute pulmonary thromboembolism.
    Findik S; Erkan ML; Selçuk MB; Albayrak S; Atici AG; Doru F
    Respiration; 2002; 69(5):440-4. PubMed ID: 12232452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bemiparin: a review of its use in the prevention of venous thromboembolism and treatment of deep vein thrombosis.
    Chapman TM; Goa KL
    Drugs; 2003; 63(21):2357-77. PubMed ID: 14524738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.